公司资料
CONMED 股价、新闻与催化剂
- 股票代码:
- CNMD
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
45.93 USD (-0.65%)
收盘价
最后更新: 2026年10月1日
1.02B USD
市值
股价为何变动
截至 2026年10月1日，CNMD 下跌 0.65%，收于 $45.93。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Surgical Medical Technology Company
CONMED develops devices and equipment used by surgeons in orthopedics, general surgery, gynecology, thoracic surgery, and other minimally invasive specialties.
Orthopedic Surgery Portfolio
The orthopedic business includes sports-medicine implants, powered surgical instruments, visualization systems, and related disposable products used in arthroscopic and open procedures.
General Surgery Portfolio
General Surgery includes electrosurgical devices, smoke evacuation, insufflation, fluid management, and other products used in laparoscopic, robotic, and open surgery.
AirSeal and Buffalo Filter Platforms
AirSeal supports stable pneumoperitoneum and smoke evacuation during minimally invasive and robotic procedures, while Buffalo Filter provides surgical-smoke management. Both platforms combine installed equipment with procedure-based disposable demand.
BioBrace Soft-Tissue Reinforcement
BioBrace is a bioinductive scaffold used to reinforce soft-tissue repairs. It expands CONMED's exposure to sports-medicine procedures where surgeons seek both immediate mechanical strength and biological healing support.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。